
Agenus/LinkedIn
Jun 27, 2025, 09:53
Benjamin Schlechter Will Present New Long-Term Follow-Up Data from the Phase 1 Study With MSS – Agenus
Agenus shared on LinkedIn:
“Looking ahead to ESMOGI25: Dr. Benjamin Schlechter from Dana-Farber Cancer Institute will present new long-term follow-up data from the Phase 1 study with microsatellite stable (MSS) metastatic colorectal cancer patients.
Stop by our poster next week at the 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress in Barcelona, Spain.
Learn more about the abstract.”
More posts featuring ESMOGI25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 27, 2025, 08:58
Jun 27, 2025, 07:51